SFX by Ex Libris Inc.

Title:	Aryl hydrocarbon receptor control of a disease tolerance defence pathway
Source:	Nature [0028-0836] Bessede, A yr:2014

Basic

Full text

Full text available via Nature

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Denison, MS S. "Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals." Annual review of pharmacology and toxicology 43.1 (2003): 309-334.
description	2.	Ma, Q. "Influence of light on aryl hydrocarbon receptor signaling and consequences in drug metabolism, physiology and disease." Expert Opinion on Drug Metabolism and Toxicology 7.10 (2011): 1267-1293.
description	3.	Boitano, Anthony E. "Aryl Hydrocarbon Receptor Antagonists Promote the Expansion of Human Hematopoietic Stem Cells." Science 329.5997 (2010): 1345-1348.
description	4.	Pachner, Andrew R. "Increased expression of B-lymphocyte chemoattractant, but not pro-inflammatory cytokines, in muscle tissue in rhesus chronic Lyme borreliosis." Cytokine 19.6 (2002): 297-307.
description	5.	Matsumoto, K. "NK4 (HGF-antagonist/angiogenesis inhibitor) in cancer biology and therapeutics." Cancer Science 94.4 (2003): 321-7.
description	6.	Denison, Michael S. "Ligand binding and activation of the Ah receptor." Chemico-biological interactions 141.1-2 (2002): 3-24.
description	7.	Singh, Kameshwar P. "Aryl Hydrocarbon Receptor-Null Allele Mice Have Hematopoietic Stem/Progenitor Cells with Abnormal Characteristics and Functions." Stem cells and development 20.5 (2010): 769-84.
description	8.	Quintana, Howard L L. "Control of T-reg and TH17 cell differentiation by the aryl hydrocarbon receptor." Nature 453.7191 (2008): 65-71.
description	9.	Hestermann, E. "Relative Contributions of Affinity and Intrinsic Efficacy to Aryl Hydrocarbon Receptor Ligand Potency." Toxicology and Applied Pharmacology 168.2 (2000): 160-172.
description	10.	Funakoshi, H. "Modulation of Tryptophan Metabolism, Promotion of Neurogenesis and Alteration of Anxiety-Related Behavior in Tryptophan 2,3-Dioxygenase-Deficient Mice." International journal of tryptophan research 4.4 (2011): 7-18.
description	11.	Quintana, Francisco J. "The aryl hydrocarbon receptor: A molecular pathway for the environmental control of the immune response." Immunology 138.3 (2012): 183-189.
description	12.	Yu, S. "A novel liquid chromatography/tandem mass spectrometry based depletion method for measuring red blood cell partitioning of pharmaceutical compounds in drug discovery." Rapid communications in mass spectrometry 19.2 (2005): 250-254.
description	13.	Ma, Q. "Pharmacogenetics, Pharmacogenomics, and Individualized Medicine." Pharmacological reviews 63.2 (2011): 437-459.
description	14.	Babcock, T. "Transcriptional activation of indoleamine dioxygenase by interleukin 1 and tumor necrosis factor alpha in interferon-treated epithelial cells." Cytokine 12.6 (2000): 588-594.
description	15.	Xu, Q. "Modification of Borrelia burgdorferi to overproduce OspA or VlsE alters its infectious behaviour." Microbiology 154.11 (2008): 3420-3429.
description	16.	Conrad, Kelly L L. "Formation of accumbens GluR2-lacking AMPA receptors mediates incubation of cocaine craving." Nature 454.7200 (2008): 118-21.
description	17.	POLAND, A. "2,3,7,8-TETRACHLORODIBENZO-PARA-DIOXIN AND RELATED HALOGENATED AROMATIC-HYDROCARBONS - EXAMINATION OF THE MECHANISM OF TOXICITY." Annual review of pharmacology and toxicology 22.1 (1982): 517-554.
description	18.	Hill, E. "Designing scaffolds to enhance transplanted myoblast survival and migration." Tissue engineering 12.5 (2006): 1295-1304.
description	19.	Trowbridge, Jennifer J J. "Glycogen synthase kinase-3 is an in vivo regulator of hematopoietic stem cell repopulation." Nature medicine 12.1: 89-98.
description	20.	Mellor, A L L. "Tryptophan catabolism and T-cell tolerance: immunosuppression by starvation?" Immunology today 20.10: 469-473.